Institutional Ownership Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 238,600 shares, which have been reported (via 13F filing form) to have a value of $150,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
160,000
shares
|
$120,000
0.28% of portfolio
|
Q4 2021
New holding
|
|
|
Clear Street LLC
|
May 15, 2025 Q1 2025 |
65,759
shares
|
$49,319
0.0% of portfolio
|
Q1 2025
Added 0.15%
|
|
|
Warberg Asset Management LLC
Winnetka, IL |
May 09, 2025 Q1 2025 |
10,000
shares
|
$7,500
0.02% of portfolio
|
Q1 2025
Reduced 44.25%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,841
shares
|
$2,130
0.0% of portfolio
|
Q1 2025
Added 2922.34%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|